Healthcare Global Enterprises
Healthcare Global Enterprises (HCG), headquartered in India, is a leading player in the oncology and healthcare sector. Established in 2001, HCG has made significant strides in providing comprehensive cancer care, with a network of hospitals and clinics across major operational regions in India and beyond. HCG is renowned for its advanced cancer treatment services, including radiation therapy, chemotherapy, and surgical oncology, distinguished by its commitment to personalised patient care and cutting-edge technology. The company has achieved notable milestones, such as being the first to introduce a dedicated cancer hospital in India, solidifying its position as a pioneer in the industry. With a focus on innovation and excellence, HCG continues to enhance its market position, recognised for its high standards of care and successful patient outcomes.
DitchCarbon Score
How does Healthcare Global Enterprises's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Healthcare Global Enterprises's score of 39 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Healthcare Global Enterprises's reported carbon emissions
In 2023, Healthcare Global Enterprises reported total carbon emissions of approximately 22,769,130 kg CO2e, comprising 2,929,130 kg CO2e from Scope 1, 21,769,000 kg CO2e from Scope 2, and 6,800,000,000 kg CO2e from Scope 3 emissions. This represents a significant reduction in Scope 1 emissions compared to 2022, where they were approximately 118,000,000 kg CO2e, and a slight increase in Scope 2 emissions from 17,100,000 kg CO2e. For 2024, the company anticipates further reductions, with projected Scope 1 emissions of about 981,240 kg CO2e and Scope 2 emissions of approximately 34,088,950 kg CO2e. However, Scope 3 emissions remain unchanged at 6,800,000,000 kg CO2e. Despite these figures, Healthcare Global Enterprises has not disclosed specific reduction targets or climate pledges, indicating a potential area for improvement in their sustainability strategy. The company operates within a sector that is increasingly scrutinised for its environmental impact, highlighting the importance of transparent climate commitments and measurable reduction initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 118,000,000 | 0,000,000 | 000,000 |
| Scope 2 | 171,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 6,800,000,000 | 0,000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Healthcare Global Enterprises is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
